Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers

European Journal of Pharmaceutical Sciences

Volumn 48, Issue 1-2, 2013, Pages 40-46

  Cabrales, Ania ^a   Gil, Jeovanis ^a   Fernández, Eduardo ^b   Valenzuela, Carmen ^a   Hernández, Francisco ^a   García, Idrián ^a   Hernández, Ariadna ^a   Besada, Vladimir ^a   Reyes, Osvaldo ^a   Padrón, Gabriel ^a   Berlanga, Jorge ^a   Guillén, Gerardo ^a   González, Luis Javier ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b UNIVERSITY OF HAVANA   (Cuba)

Author keywords

Enterohepatic recycling; GHRP 6; Half life; Intravenous administration; Pharmacokinetics; Quantitative LC MS

Indexed keywords

CARBON 13; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; HUMAN EXPERIMENT; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AREA UNDER CURVE; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH HORMONE-RELEASING HORMONE; HUMANS; MALE; OLIGOPEPTIDES; YOUNG ADULT;

EID: 84869869341     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.10.006     Document Type: Article

References (28)

1. H. Akaike Fitting autoregressive models for prediction Ann. Inst. Stat. Math. 21 1969 243 247
2. S. Bansal, and A. DeStefano Key elements of bioanalytical method validation for small molecules AAPS J. 9 2007 E109 E114
3. J. Berlanga, D. Cibrian, L. Guevara, H. Dominguez, J. Alba, A. Seralena, G. Guillen, E. Lopez-Mola, P. Lopez-Saura, A. Rodriguez, B. Perez, D. Garcia, and N.S. Vispo Growth-Hormone-Releasing Peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction Clin. Sci. 112 2007 241 250
4. C.J. Briscoe, M.R. Stiles, and D.S. Hage System suitability in bioanalytical LC/MS/MS J. Pharm. Biomed. Anal. 44 2007 484 491
5. A. Brüel, T.E.H. Christoffersen, and J.R. Nyengaard Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart Cardiovasc. Res. 76 2007 400 408
6. M.E. Burton Applied pharmacokinetics & pharmacodynamics: principles of therapeutic drug monitoring W.J. Jusko, Guidelines for Collection and Analysis of Pharmacokinetic Data 2006 Lippincott Williams & Wilkins 8 (Chapter 2)
7. M. Carrascal, K. Schneider, R.E. Calaf, S. Leeuwen, van, D. Canosa, E. Gelpi, and J. Abian Quantitative electrospray LC-MS and LC-MS/MS in biomedicine J. Pharm. Biomed. Anal. 17 1998 1129 1138
8. D. Chang, S.J. Kolis, K.H. Linderholm, T.F. Julian, R. Nachi, A.M. Dzerk, P.P. Lin, J.W. Lee, and S.K. Bansal Bioanalytical method development and validation for a large peptide HIV fusion inhibitor (Enfuvirtide, T-20) and its metabolite in human plasma using LC-MS/MS J. Pharm. Biomed. Anal. 38 2005 487 496
9. P. Chanson, J. Timsit, and A.G. Harris Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours Clin. Pharmacokinet. 25 1993 375 391
10. D. Cibrián, H. Ajamieh, J. Berlanga, O.S. León, J.S. Alba, M.J. Kim, T. Marchbank, J.J. Boyle, F. Freyre, D. Garcia Del Barco, P. Lopez-Saura, G. Guillen, S. Ghosh, R.A. Goodlad, and R.J. Playford Use of Growth-Hormone-Releasing Peptide-6 (GHRP-6) for the prevention of multiple organ failure Clin. Sci. 110 2006 563 573
11. S. Darby, M. Miller, R. Allen, and M. LeBeau A mass spectrometric method for quantitation of intact insulin in blood samples J. Anal. Toxicol. 25 2001 8 14
12. R.C. Dart Medical toxicology Dimercaprol Elimination Enhancement third ed.; illustrated 2004 Lippincott Williams & Wilkins 330
13. C.B. Davis, C.S. Crysler, V.K. Boppana, K.L. Fong, G.L. Joseph, J.J. Urbanski, R.A. Macia, and G.R. Rhodes Disposition of growth hormone-releasing peptide (SK&F 110679) in rat and dog following intravenous or subcutaneous administration Drug Metab. Dispos. 22 1994 90 98
14. R. Deghenghi, M.M. Cananzi, A. Torsello, C. Battisti, E.E. Muller, and V. Locatelli GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats Life Sci. 54 1994 1321 1328
15. G.B. Fields, and R.L. Noble Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids Int. J. Pept. Prot. Res. 35 1990 161 214
16. J. Gil, A. Cabrales, O. Reyes, V. Morera, L. Betancourt, A. Sánchez, G. García, G. Moya, G. Padrón, V. Besada, and L.J. González Development and validation of a bioanalytical LC-MS method for the quantification of GHRP-6 in human plasma J. Pharm. Biomed. Anal. 60 2012 19 25
17. K.A. Hoffmaster, M.J. Zamek-Gliszczynski, G.M. Pollack, and K.L. Brouwer Multiple transport systems mediate the hepatic uptake and biliary excretion of the metabolically stable opioid peptide [D-penicillamine2,5] enkephalin Drug Metab. Dispos. 33 2005 287 293
18. M. Okano, M. Sato, A. Ikekita, and S. Kageyama Determination of Growth Hormone Secretagogue Pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem Mass Spectrometry Rapid Commun. Mass Spectrom. 24 2010 2046 2056
19. C. Pihoker, G.L. Kearns, D. French, and C.Y. Bowers Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children J. Clin. Endocrinol. Metab. 83 1998 1168 1172
20. M. Roumi, S. Marleau, P. du Souich, T. Maggi, R. Deghenghi, and H. Ong Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats Drug Metab. Dispos. 28 2000 44 50
21. R.G. Smith, O.C. Palyha, S.D. Feighner, C.P. Tan, K.K. McKee, D.L. Hreniuk, L. Yang, G. Morriello, R. Nargund, A.A. Patchett, and A.D. Howard Growth hormone releasing substances: types and their receptors Horm. Res. 51 1999 1 8
22. H.H. Szeto Mitochondria-targeted peptide antioxidants: novel neuroprotective agents AAPS J. 8 2006 521 531
23. H.H. Szeto, J.L. Lovelace, G. Fridland, Y. Soong, J. Fasolo, D. Wu, D.M. Desiderio, and P.W. Schiller In vivo pharmacokinetics of selective μ-opioid peptide agonists J. Pharmacol. Exp. Ther. 298 2001 57 61
24. A. Thomas, S. Höppner, H. Geyer, W. Schänzer, M. Petrou, D. Kwiatkowska, A. Pokrywka, and M. Thevis Determination of Growth Hormone Releasing Peptides (GHRPs) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry ABC 401 2011 507 516
25. WinNonlin v3.0 Reference guide, 2000. Mountain view (CA). Pharsight Corporation.
26. L. Xiaoling Oral bioavailability: basic principles, advanced concepts and applications Pharmacokinetic Behaviors of Orally Administered Drugs 2011 John Wiley & Sons pp. 197
27. J.Z. Yang, W. Chen, and R.T. Borchardt In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs J. Pharmacol. Exp. Ther. 303 2002 840 848
28. K. Younggil Handbook of essential pharmacokinetics Pharmacodynamics and Drug Metabolism for Industrial Scientists 2002 Kluwer Academic Publishers pp. 68-69